Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Buff (NPI 1699811547)

Field	Value
Entity Type	Individual
Organization	Michael Buff
Address	250 Pleasant St
City	Concord
State	NH
ZIP	03301
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	January 29, 2007

Payer Source	Total Paid
Medicare	$387.2K
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the only payer activity on file: Total Medicare revenue is reported as $387.2K and there is no Medicaid billing on file, making the practice effectively single-payer (Medicare) in the available public claims data. That concentration implies the provider’s downstream contract negotiations and patient mix analysis should be considered through a Medicare-centric lens rather than a dual-payer strategy.

Revenue concentration is strongly focused in three codes: the top 3 Medicare codes account for 78.5% of this provider’s total Medicare revenue, driven by J9271 at $205.2K (53.5% of Medicare revenue), 99214 at $67.7K (17.6%), and 99213 at $28.5K (7.4%). This level of concentration indicates a small number of services—one high-cost drug and routine outpatient visits—dominate reimbursement.

The service mix indicates an outpatient oncology practice that couples high-cost immunotherapy dispensing with frequent office follow-up: J9271 (pembrolizumab) is the largest revenue source and 99214/99213 are the principal E/M visit codes supporting continuity care. Additional chemotherapy administration codes such as 96413 (238 claims, $25.2K; 6.6% of Medicare revenue) and add-on infusion codes (e.g., 96417, 96415) further support an infusion-capable ambulatory oncology workflow rather than a procedure-only or inpatient-focused operation.

Despite J9271 representing the single largest revenue line ($205.2K, 53.5%), the provider’s national rank on that code is modest: J9271 ranks #1664 of 1841 providers nationally (9th percentile) and is characterized as typical, unremarkable volume for this code. In other words, a majority of the practice’s Medicare dollars come from a high-priced drug even though their national dispensing volume for that drug is not concentrated among top providers.

Office visit activity is a relative strength versus national peers. 99214 generates $67.7K and ranks #21422 of 479517 providers nationally (96th percentile) and is labeled notably above typical national volume, while 99213 generates $28.5K and ranks #26232 of 457151 providers nationally (94th percentile) and is labeled typical, unremarkable volume for this code; together these visit codes form a consistent ambulatory evaluation-and-management base that outperforms most peers on higher-level visits.

Chemotherapy administration activity is present but not dominant: 96413 accounts for $25.2K (6.6% of Medicare revenue) and ranks #2462 of 7514 providers nationally (67th percentile) with the label typical, unremarkable volume for this code. The pattern of multiple administration and add-on infusion codes (96417, 96411, 96367, 96375) indicates routine multi-drug and extended infusion sessions typical of an outpatient oncology infusion suite rather than sporadic single-dose administration.

The provider has a long-tenured enrollment in Medicare, with NPI enumeration on 2007-01-29 (~19 years ago), which suggests an established practice history in the community. Coupled with modest aggregate Medicare revenue of $387.2K, this implies a stable but relatively small-scale Medicare practice rather than a high-volume regional cancer center.

The absence of Medicaid claims (none below) means the provider has no recorded Medicaid revenue to compare against Medicare, which limits assessment of state-program exposure and suggests a patient population skewed away from Medicaid beneficiaries in the available data. For payers and network planners this profile signals limited direct experience with Medicaid billing and potential implications for contracting or participation in state Medicaid arrangements.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	5,400	$40	$205.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	770	$90	$67.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	510	$60	$28.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	240	$110	$25.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	90	$130	$11.7K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	50	$160	$8.1K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	30	$220	$6K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	90	$50	$4.6K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	40	$100	$4.4K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	150	$20	$3.5K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Michael Buff — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	10	10,000	$40	$440.2K
96413	6	20	140	$100	$15.8K
99214	63	3,150	110	$80	$13.2K
99233	503	600	70	$90	$10.9K
G0498	4	10	50	$220	$10.6K
99232	665	990	70	$60	$9.8K
99213	92	2,900	70	$50	$6.9K
99215	218	1,080	40	$110	$6.8K
99205	83	440	20	$140	$4.9K
J0185	3	10	2,600	$1	$4.7K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Buff, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Elliot Professional Services	NH	Internal Medicine Physician	$0	$12.8M
Concord Hospital-franklin	NH	Critical Access Hospital	$0	$7.3M
Concord Hospital-franklin	NH	Rural Health Clinic/Center	$0	$3.6M
Lrghealthcare	NH	Family Medicine Physician	$0	$2.9M
Maxwell Elia	NH	Ophthalmology Physician	$2.3M	$0
Ahad Fazelat	NH	Ophthalmology Physician	$2.1M	$0
Anthony Correnti	NH	Ophthalmology Physician	$1.5M	$0
Gina Divenuti	NH	Hematology & Oncology Physician	$1M	$0
Frederick Briccetti	NH	Hematology & Oncology Physician	$861.3K	$0
Sumit Kunwar	MD	Rheumatology Physician	$724.6K	$0

Nearby Providers

Other providers in the same ZIP code as Michael Buff, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Bridges	NH	Case Management Agency	$0	$265.5M
Riverbend Community Mental Health, Inc.	NH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$118.4M
Granite State Independent Living	NH	In Home Supportive Care Agency	$0	$74.7M
Ascentria Community Services, Inc	NH	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$52.6M
Ascentria Community Care, Inc	NH	Voluntary or Charitable Agency	$0	$50.3M
Concord Hospital, Inc.	NH	General Acute Care Hospital	$0	$28.8M
Concord Pediatric Dentistry	NH	Pediatric Dentistry	$0	$13.6M
New England Life Care, Inc.	NH	Home Infusion Therapy Pharmacy	$0	$11.4M
New Hampshire Home Care Providers LLC	NH	In Home Supportive Care Agency	$0	$11M
Brain Injury Association Of Nh	NH	Case Management Agency	$0	$11M

Michael Buff — Billing Profile & Reimbursement Data

Sign up for Michael Buff — Billing Profile & Reimbursement Data policy alerts

Michael Buff — Billing Profile & Reimbursement Data

Sign up for Michael Buff — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References